| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/2009 | US20090238867 Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238858 Compositions and Methods for Treating Ophthalmic Diseases |
| 09/24/2009 | US20090238845 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 09/24/2009 | US20090238836 Hip kinase for fertility control |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238826 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |
| 09/24/2009 | US20090238818 Induction of Antigen Specific Immunnologic Tolerance |
| 09/24/2009 | US20090238817 Anti-cell proliferative compounds and methods of use |
| 09/24/2009 | US20090238814 Compositions and methods for treating hypophosphatasia |
| 09/24/2009 | US20090238813 Compositions And Methods For Engineered Human Arginine Deiminases |
| 09/24/2009 | US20090238812 Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery |
| 09/24/2009 | US20090238811 Enzymatic Antimicrobial and Antifouling Coatings and Polymeric Materials |
| 09/24/2009 | US20090238808 Process for the identification of novel enzyme interacting compounds |
| 09/24/2009 | US20090238802 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells |
| 09/24/2009 | US20090238795 In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors |
| 09/24/2009 | US20090238794 Fluorinated macrocyclic compounds as hepatitis c virus inhibitors |
| 09/24/2009 | US20090238793 Toll like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration |
| 09/24/2009 | US20090238792 Suppression of postoperative ileus |
| 09/24/2009 | US20090238791 Il-15ralpha sushi domain as a selective and potent enhancer of il-15 action through il-15beta/gamma, and hyperagonist (il-15ralpha sushi - il-15) fusion proteins |
| 09/24/2009 | US20090238790 Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections |
| 09/24/2009 | US20090238789 Modified erythropoietin polypeptides and uses thereof |
| 09/24/2009 | US20090238788 Delivery of hydrogels as sprays |
| 09/24/2009 | US20090238758 Random and non-random alkylene oxide polymer alloy compositions |
| 09/24/2009 | US20090238757 Methods and Compositions for Administering Therapeutic and Diagnostic Agents |
| 09/24/2009 | US20090238754 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | DE102008014760A1 Imidazolium-Salze als Enzymstabilisatoren Imidazolium salts as enzyme stabilizers |
| 09/24/2009 | CA2718966A1 Anti-inflammatory drug delivery system |
| 09/24/2009 | CA2718949A1 Peptide compositions for cancer treatment |
| 09/24/2009 | CA2718915A1 Pharmaceutical composition and a method for the production thereof |
| 09/24/2009 | CA2718884A1 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | CA2718854A1 Inhibition of angiogenesis |
| 09/24/2009 | CA2718768A1 Tpa mutant in the treatment of acute brain injury and neurodegenerative disorders |
| 09/24/2009 | CA2718738A1 Protease stabilized, acylated insulin analogues |
| 09/24/2009 | CA2718715A1 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | CA2718706A1 Partial peptide of lacritin |
| 09/24/2009 | CA2717954A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 09/24/2009 | CA2717459A1 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 09/24/2009 | CA2717419A1 Synergic 5'-methylthioadenosine combinations |
| 09/24/2009 | CA2717365A1 Methods of treating inflammation |
| 09/24/2009 | CA2714708A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/24/2009 | CA2713884A1 Crystalline structure of the cc2-lz domain of nemo |
| 09/23/2009 | EP2103691A1 T helper cell epitopes |
| 09/23/2009 | EP2103684A1 Vascularisation enhanced graft constructs |
| 09/23/2009 | EP2103630A1 Preparation of low bleeding anticoagulant fusion protein and its use |
| 09/23/2009 | EP2103629A1 Gamma -1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 09/23/2009 | EP2103626A1 Alleviation of the memory deficits and memory components of psychiatric dysfuntions by altering atypical PKM activity |
| 09/23/2009 | EP2103624A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/23/2009 | EP2103623A2 Novel macrocyclic inhibitors of Hepatitis C virus replication |
| 09/23/2009 | EP2103310A1 Method for the prevention or treatment of ischemia reperfusion injury. |
| 09/23/2009 | EP2102346A2 Yeast biocatalysts for degradation of biowarfare agents |
| 09/23/2009 | EP2102236A2 Gp100-specific t cell receptors and related materials and methods of use |
| 09/23/2009 | EP2102235A1 Treatment of cachexia |
| 09/23/2009 | EP2102234A2 Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain |
| 09/23/2009 | EP2102233A2 Mutated netrin 4, fragments thereof and uses thereof as drugs |
| 09/23/2009 | EP2102229A1 Pyrrolydine derivatives as iap inhibitors |
| 09/23/2009 | EP2101877A2 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 09/23/2009 | EP2101811A2 Vaccine for periodontitis and methods of use |
| 09/23/2009 | EP2101810A2 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/23/2009 | EP2101809A1 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 09/23/2009 | EP2101808A2 Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity |
| 09/23/2009 | EP2101807A2 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 09/23/2009 | EP2101806A2 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor |
| 09/23/2009 | EP2101805A2 Specific therapy and medicament using integrin ligands for treating cancer |
| 09/23/2009 | EP2101804A2 Pro-angiogenic peptides |
| 09/23/2009 | EP2101802A2 Inhibiting collagen-induced platelet aggregation and activation with peptide variants |
| 09/23/2009 | EP2101801A1 Oral delivery of polypeptides |
| 09/23/2009 | EP1987063B1 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 09/23/2009 | EP1621207B1 Mixture of defibrotide and G-CSF, and its use for activating haematopoietic progenitors |
| 09/23/2009 | EP1606406B1 SHORT INTERFERING RNA (siRNA) ANALOGUES |
| 09/23/2009 | EP1581557B1 Metastin derivatives and their use |
| 09/23/2009 | EP1567539B1 Allele-specific rna interference |
| 09/23/2009 | EP1558632B1 Macrocyclic peptides active against the hepatitis c virus |
| 09/23/2009 | EP1542528B1 A method of treatment and prophylaxis |
| 09/23/2009 | EP1478662B1 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP1420827B1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/23/2009 | EP1283682B1 Tryptophan source from plants and uses therefor |
| 09/23/2009 | EP1234880B9 Novel protein tab2 |
| 09/23/2009 | EP1143808B1 Method of making ingestible compositions comprising antibacterial agents |
| 09/23/2009 | EP1086138B1 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 09/23/2009 | EP1073734B1 Tumor associated nucleic acids and uses therefor |
| 09/23/2009 | EP1003781B1 Interleukin-18 binding proteins, their preparation and use |
| 09/23/2009 | EP0863981B1 Detection, prevention and treatment of papillomatous digital dermatitis |
| 09/23/2009 | CN101541341A Analogs of ghrelin substituted at the N-terminal |
| 09/23/2009 | CN101538557A Recombinant human divalent metal ion transporter adenovirusm and preparation method and application thereof |
| 09/23/2009 | CN101538331A Single chain antibody-lidamycin fusion protein ER (Fv-LDP) targeting EGFR |
| 09/23/2009 | CN101538320A Artificial zinc finger protein transcription factor capable of specifically regulating up HO-1 gene expression and application thereof |
| 09/23/2009 | CN101538319A Polypeptide for detecting polytype human papilloma virus and application thereof |
| 09/23/2009 | CN101538313A Peptide-based compounds |
| 09/23/2009 | CN101538311A Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
| 09/23/2009 | CN101537190A Peptide-based compounds |
| 09/23/2009 | CN101537177A Drug with thrombus-curing function and preparation method thereof |
| 09/23/2009 | CN101537176A Application of staphylococcus lysozyme compound in preparing medicament improving animal health condition |
| 09/23/2009 | CN101537175A Four-program integral therapy |
| 09/23/2009 | CN101537174A Health preserving calcium |
| 09/23/2009 | CN101537173A Preparations stabilized over long time |
| 09/23/2009 | CN101537172A Recombinant human keratinocyte growth factor-2 containing eye drops and method for preparing same |
| 09/23/2009 | CN101537171A Preparation method and clinical application of poliosis-treating medicament |